Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th June 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EMA committee recommends first stem cell-based veterinary medicine
Arti-cell Forte is recommended for use in horses with mild to moderate lameness related to joint inflammation.
Arti-cell Forte indicated for use in horses with lameness

The first stem cell-based veterinary medicine has been recommended for marketing authorisation in the European Union by The European Medicines Agency's (EMA) Committee for Medicinal Products (CVMP).

Arti-cell Forte is recommended for use in horses with mild to moderate lameness related to joint inflammation. It is available as a suspension for injection and is given as a single injection into the affected joint.

In a press release, the EMA said the stem cells in the medicine are treated so they develop towards cartilage cells. This can then help to repair damaged cartilage in the joint.

‘In a field study conducted in horses with lameness of the fetlock joint, Arti-Cell Forte showed a statistically significant improvement in the horses treated with the medicine compared with a placebo control group six weeks after treatment,’ the EMA writes. ‘The positive effect of treatment was sustained over one year.’

Common side effects of the medicine reported in the study were mild increase in lameness and injection site reactions in the week following treatment.

The CVMP’s recommendation will now be passed on to the European Commission for a decision on an EU-wide marketing authorisation. 

Become a member or log in to add this story to your CPD history

Webinar to explore history of KC breed registers

News Story 1
 A free webinar exploring the development of the Kennel Club's registration system and the evolution of closed breed registers has been announced.

Hosted by Dr Alison Skipper, veterinary and research advisor at the Kennel Club, the webinar will delve into the development of the registry and how the changing landscape of scientific knowledge has shaped breeding practices. It will also look at what this means for the future of pedigree dogs.

The session will culminate with a look at The Kennel Club's ongoing and future engagement in this area, with a chance for attendees to put forward their thoughts and questions for discussion.

This event takes place on Microsoft Teams on Tuesday, 10 June at 7pm. To learn more, visit events.teams.microsoft.com  

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.